Gynecologist Millicent Francis-Lane, MD, has agreed to pay $950,000 to the North Carolina Medicaid Program to resolve False Claims Act allegations related to upcoding, according to a news release from U.S. Attorney Anne M. Tompkins. Dr. Francis-Lane owns Union County…
The Latest
A new study found integrating genetic testing with a multidisciplinary team approach improves timely evaluation of patients and awareness of genetic implications with regard to cancer risk, according to findings published in the November issue of Archives of Ophthalmology.
The Healthcare Plastics Recycling Council released a set of guidelines that identifies product and packaging design features that inhibit post-use recycling potential and makes design recommendations that could enhance product recyclability, according to a council press release.
The Consumers Union wrote a letter asking Congress to strengthen the governing laws for medical device approval to ensure patient safety, according to a Sacramento Bee report.
Isoflurane and deflurane may have different effects on postoperative cognitive function, according to a study published in the Nov. 2011 issue of Anesthesia & Analgesia.
House-Senate negotiations resulted in a bill that would increase the FDA's budget by $50 million from last year to a total of $2.5 billion, according to an Atlanta Journal-Constitution report.
Three pain clinic owners, two physicians and seven pharmacists from seven metro Atlanta counties were arrested as a result of a yearlong investigation by the DEA and the DeKalb County District Attorney’s Office, according to an Atlanta Journal-Constitution report.
Application of topical anesthetic drops may be more effective at reducing pain caused by intravitreal injection, according to an OSN SuperSite report.
A study from Norway found the more often women experienced sleep problems, the more likely they were to develop fibromyalgia 10 years later, according to a CNN report.
A new report looks at cancer drug development strategies in colorectal cancer, lung cancer and the compound strategy of antibodies to compare drug development strategies in oncology, according to a Research and Markets news release.